Insider trades
Daniel Allen Gold, Director of Roivant Sciences ROIV, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $147.4M. The latest trade was on 06/30.
Daniel Allen Gold
Director
- Company
- Roivant Sciences ROIV
- First filing
- 23/09/14
- Trades
- 51 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$147.4M
- Last trade
- 06/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ROIV | Open-market sale | 06/26–06/30 | 06/30 | 1,438,163 sh5 trades | $34.32avg. | $49,354,075.76 | −9.5% |
ROIV | Open-market sale | 02/11–02/13 | 02/13 | 1,225,784 sh5 trades | $26.64avg. | $32,658,518.16 | −7.5% |
ROIV | Open-market sale | 25/12/16–25/12/17 | 25/12/18 | 1,694,614 sh5 trades | $23.05avg. | $39,065,213.44 | −9.4% |
ROIV | Open-market sale | 25/11/19 | 25/11/21 | 1,300,000 sh4 trades | $20.23avg. | $26,304,500 | −6.7% |
ROIV | Open-market sale | 24/09/24–24/09/26 | 24/09/26 | 4,426,000 sh6 trades | $11.71avg. | $51,837,820.16 | No record |
ROIV | Open-market sale | 23/09/28 | 23/10/02 | 10,000,000 sh6 trades | $11.55avg. | $115,500,000 | −66.6% |